Breaking News
Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.

Have a question about
PRISTIQ?
Talk live with a PRISTIQ
representative about product
information, sample requests,
and more. All you need is a
phone and a web browser.
Talk live now >>

Health Care Professionals Log In

Already Registered with Wyeth.com?

To view more information about PRISTIQ, please log in to your Wyeth.com account.

Log in or Register for Wyeth.com

Your registration gives you access to a wealth of information, including:

  • Educational Programs
  • Professional Resources
  • Wyeth Professional Tools – A.D.A.M. QuickSheets, 5-Minute Clinical Consult, Epocrates®, and more
Register with Wyeth.com
Pristiq

References

  1. PRISTIQ® (desvenlafaxine) Prescribing Information, Wyeth Pharmaceuticals Inc.
  2. Data on file, Wyeth Pharmaceuticals Inc.
  3. Muth EA, Moyer JA, Haskins JT, et al. Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res. 1991;23:191-199.
  4. Troy SM, Dilea C, Martin PT, et al. Bioavailability of once-daily venlafaxine extended release compared with the immediate-release formulation in healthy adult volunteers. Curr Ther Res. 1997;58:492-503.
  5. Sheehan DV. Sheehan Disability Scale. In: Rush AJ Jr, Pincus HA, First MB, et al., eds. Handbook of Psychiatric Measures, 1st ed. Washington, DC: American Psychiatric Association; 2000:100, 113-115, 526-532.
  6. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391-396.
  7. EFFEXOR XR® (venlafaxine HCl) Extended-Release Prescribing Information, Wyeth Pharmaceuticals Inc.

259968-01